Augustine Lawlor - Jan 26, 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Chief Operating Officer
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Augustine Lawlor
Stock symbol
LPTX
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 08:38 PM
Previous filing
Sep 1, 2023
Next filing
Jan 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LPTX Common Stock Options Exercise +5K +5813.95% 5.09K Jan 26, 2024 Direct F1, F2
holding LPTX Common Stock 262K Jan 26, 2024 HCV VIII Liquidating Trust F3
holding LPTX Common Stock 414K Jan 26, 2024 By HealthCare Ventures IX, L.P. F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Restricted Stock Units Options Exercise $0 -5K -100% $0.00* 0 Jan 26, 2024 Common Stock 5K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units convert into common stock on a one-for-one basis.
F2 The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.
F3 The reporting person is the Manager of HCV VIII Liquidating Trust and maintains shared voting and dispositive power over the shares held by HCV VIII Liquidating Trust. The reporting person disclaims beneficial ownership of the shares held by HCV VIII Liquidating Trust except to the extent of his proportionate pecuniary interest therein.
F4 The reporting person is a Managing Director of HealthCare Partners IX, LLC which is the General Partner of HealthCare Partners IX, L.P., which is the General Partner of HealthCare Ventures IX, L.P. The reporting person beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.
F5 On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.